News & Articles

This new oncology service supports unique in vitro investigations into the PK/PD relationship

Syukuro Manabe, Klaus Hasselmann and Giorgio Parisi honored for their groundbreaking contributions to our understanding of complex physical systems

Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease.

Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments

Advance your biopharma research through HPLC with this first-of-its-kind application-focused resource

ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community

The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years

The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

The latest discoveries show potential in resolving persistent challenges in healthcare and lab testing for women

The new machine learning tool could help healthcare workers to quickly screen and direct the flow of COVID-19 patients arriving at hospitals

Can a healthy lifestyle combat undernutrition and dementia?

Today’s activities are part of ongoing implementation of new authorities for certain over-the-counter drugs

ELRIG’s EDI Guiding Principles promote inclusivity and collaboration in the drug discovery community

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII

A new method of exploring chemical space could help create scientific breakthroughs in areas including drug design and discovery, its creators say.